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Michael Corey, BA, and Richard P. Cambria, MD, Boston, Mass
Objectives: Recurrent stenosis after carotid endarterectomy (CEA), previously reported to occur in 1%/year after
operation, is the finite limitation of CEA. Eversion endarterectomy has a perceived lower incidence of recurrent stenosis,
although data to support this contention are conflicting. The goal of the present study was to compare the late anatomic
results of patch closure (PC) vs eversion CEA.
Methods: Between January 1, 1995 and June 30, 2005, 950 CEA were performed by the senior author with adoption of
eversion (EV) as the primary technique as of January 1, 2001. With minimum of 1-year follow-up by study inclusion
criteria, complete follow-up data (including a duplex scan) was available for 155 PC and 135 EV patients. Incidence of
moderate (50% to 70%) and severe (>70%) restenosis was examined at <2 months and >1 year after operation. Study
end-points included late stroke, survival, and freedom from restenosis (moderate and severe) and were assessed by
actuarial methods.
Results: There were no differences in relevant demographic/clinical parameters, indication for surgery (69% overall
asymptomatic) or early perioperative stroke/death (1.1% overall; P  .25) between PC and EV. After correction for
different mean follow-up intervals (PC  5.5 years vs EV  3.5 years) by actuarial methods, there was no significant
difference in late moderate (P .91) or severe (P .54) recurrent stenosis between PC and EV. In the group of patients
with at least 1-year follow-up, 11/290 (3.8%) patients (4/135 EV, 7/155 PC; P .39) required reintervention on their
operated carotid artery at a cumulative follow-up interval of 4.5 years. Three strokes (3/290; 1.1%) occurred during late
follow-up, all in the PC group, with only one related to the operated carotid artery. Late survival was similar between EV
and PC, (P  .86). Female gender (odds ratio [OR] 3.72[1.02-13.5], P  .046) was associated with severe restenosis
irrespective of surgical technique. Univariate analysis also showed that female gender (OR 7.6[CI: 0.88-66.7], P .042)
was associated with late stroke.
Conclusion: These findings indicate that restenosis rates are similar between eversion and patch CEA and likely represent
biological remodeling phenomenon rather than technical variations of operations. While EV offers distinct advantages in
certain anatomic circumstances, adoption of EV with the hope of decreasing restenosis is not warranted. (J Vasc Surg
2007;46:41-8.)Randomized trials have validated the efficacy of carotid
endarterectomy (CEA) for stroke prevention in both symp-
tomatic and asymptomatic significant stenosis of the inter-
nal carotid artery.1-4 Perioperative stroke rates of 6% in
symptomatic patients and 3% in asymptomatic patients are
acceptable thresholds according to published guidelines.5
However, perioperative stroke rates of 2% for symptomatic
disease and 1% for asymptomatic disease are reported in
multiple contemporary surgical series.6-9 CEA is most often
performed with a longitudinal arteriotomy typically closed
with a patch, as randomized trials demonstrate that relevant
outcome measures favor patch over primary closure.10-13
An alternative approach, eversion CEA, was originally de-
scribed by DeBakey et al in the 1950s14 and involves the
oblique transection of the internal carotid artery at its
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plaque using the eversion maneuver.
The purported or demonstrated advantages of eversion
CEA include decreased operative time, avoidance of pros-
thetic material, facilitating reconstruction of a kinked or
coiled internal carotid artery (ICA), and decreased rates of
restenosis.15,16 Indeed, recurrent stenosis after CEA, which
occurs in 1%/year in our experience,17 is the limitation of
CEA, and efforts tominimize it with technical variations are
worthy of investigation. Largely as a function of this con-
sideration, the senior author (R.P.C.) adopted eversion as
the primary reconstruction mode of CEA in January of
2001. The goal of the present study was to compare the late
anatomic results of patch closure vs eversion CEA with the
inherent control of all operations being performed by a
single surgeon.
PATIENTS AND METHODS
During the interval January 1, 1995 to June 30, 2005
(to insure minimum 1-year follow-up), 950 CEAs were
performed. Procedures performed using primary closure,
those performed in conjunction with other surgical proce-
dures such as carotid artery bypass graft, valve surgery, or
coronary bypass surgery were excluded from the analysis.
After such exclusions, we examined the perioperative out-
41
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412, eversion, n  224) for perioperative death, strokes,
and myocardial infarctions. Of these 636, we identified 290
CEAs, 155 done with patch endarterectomy technique
(PC) and 135 done using the eversion technique (EV) with
at least 1-year duplex ultrasound follow-up. This study was
approved by the Institutional Review Board of the Massa-
chusetts General Hospital. Clinical and demographic data
were obtained from hospital records and office charts.
Additional telephone contact was sought for those patients
for whom recent clinical data were not available. Mortality
data were obtained using hospital records as well as data
from the National Death Index in Bethesda, Maryland.
Perioperative complications were obtained from review of
prospectively maintained weekly morbidity and mortality
statistics reported annually in quality assurance reports.
Office records were also quite detailed in this regard.
Definitions for clinical variables are as follows: hyper-
tension (HTN), use of anti-hypertensive drugs or BP
165/95 or greater on two separate occasions; renal failure
was defined as those patients undergoing dialysis or with
serum creatinine 1.5 mg/dl; diabetes (DM), fasting
blood sugar 220 mg/dl or greater or on DM meds;
hypercholesterolemia (HC), total cholesterol level of220
mg/dl or greater or currently on hypercholesterolemia
medications; peripheral vascular disease (PVD), intermit-
tent claudication in one or both limbs or prior surgical/
endovascular treatment for PVD, ischemic rest pain, or
gangrene of foot; coronary artery disease (CAD), history of
myocardial infarction (MI), angina or ventricular ectopy,
chronic heart failure or recent angina; atrial fibrillation
(AF), diagnosed by history or electrocardiogram. Ipsilateral
symptoms were those occurring in the same vascular terri-
tory as the operated carotid artery.
Primary end-points of the study included restenosis of
the operated carotid artery, perioperative and late stroke
and death. Restenosis was examined both in the “early”
(within 2 months of operation) and “late” (long-term
follow-up) time points. If, however, severe stenosis was
seen within 2 months, such patients were considered tech-
nical failures ie, persistent obstruction. “Overall” restenosis
refers to the combined “early” and “late” follow-up com-
ponents. Moderate (50% to 70% reduction in vessel diam-
eter) restenosis was defined by the following duplex crite-
ria: internal carotid artery (ICA) peak systolic velocity
(PSV) 125 cm/sec, ICA/CCA ratio 2 or end-diastolic
velocity (EDV)100 cm/sec and criteria for severe (70%
reduction in vessel diameter) restenosis with: (ICA-PSV
250, ICA/CCA ratio 4, or EDV 140).17,18 Duplex
exams were typically obtained in the immediate postoper-
ative (within 2 months) period and at 1 year. Follow-up
duplex exams (ie, those not conducted in our vascular
laboratory) were required to have actual velocity data to be
included in the group with “adequate” ultrasound follow-
up. Perioperative and late stroke was defined as a persistent
neurological deficit lasting 24 hours and generally con-
firmed by brain imaging. Freedom from restenosis and
death were analyzed using Kaplan-Meier life table analysis.The Rankin Score for functional assessment after stroke is
defined elsewhere.19
Secondary end-points included myocardial infarction
(MI), redo CEA, operative site hematomas (not necessarily
requiring operation), perioperative transient ischemic at-
tacks or amaurosis fugax (TIA/AFX), cranial nerve injury
(persistent deficit at 1 month after surgery), and retinal
infarcts. MI was confirmed by positive laboratory enzyme
and electrocardiograph (ECG) analysis. Enzyme analysis
was obtained only after routine postoperative ECG analysis
showed new abnormalities. TIA/AFX was defined as an
acute disturbance of focal neurological or monocular func-
tion with symptoms lasting 24 hours. Retinal infarct was
defined as total or partial monocular loss of vision with
symptoms persisting longer than 24 hours, with diagnosis
confirmed by an ophthalmologist.
Procedures. All procedures were performed generally
with patch carotid endarterectomy until the beginning of
2001 when preferentially the eversion technique was used.
Operative procedures were most often performed under
general anesthesia with electroencephalographic monitor-
ing and selective shunting. Electroencephalogram (EEG)
changes dictated a preference towards longitudinal arteri-
otomy and patch to facilitate shunting. A description of the
eversion technique has been published elsewhere.15 Over-
all, regional anesthesia was performed in seven (2.4%)
patients (2/135 for EV, 5/155 for PC). Intraprocedural
verification of the technical result of operation is limited to
a qualitative hand-held Doppler interrogation. Intraopera-
tive shunting was used in 41 (14.1%) of patients, all in the
patch group. EEG slowing was observed in 25 (8.6%) of
patients, 22 (14.2%) of them in the patch group, and three
(2.2%) in the eversion group. Overall, 30.3 % of patients
were operated on for symptomatic disease (see Table I),
29.7% of patients in the patch group and 31.0% of patients
for the eversion group.
For redo CEA, only preocclusive (90%; residual lu-
men diameter1.5 mm) lesions verified by angiography as
critical (in earlier years), or duplex and CTA in more recent
years underwent reintervention. Two patients treated for
restenosis with carotid stents also had angiography.
Statistical methods. Cohort comparisons of demo-
graphic data were assessed using two-tailed t-tests for con-
tinuous variables, 2 and Fischer exact t tests for categorical
data. Late outcomes were assessed using Kaplan-Meier life
table analysis and the log-rank test was used when compar-
ing subgroups across comparable time intervals. Univariate
analysis of variables potentially associated with study end-
points was performed, and those that were statistically
significant (threshold of 0.05) were included in a multiple
logistic regression in order to identify predictors of late
outcomes.
RESULTS
The patch group (n  155) differed from the eversion
(n  135) group in four clinical domains as displayed in
Table II. The higher incidence of “hypercholesterolemia”
ks.
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of HMG-CoA reductase inhibitors since 2001.
Perioperative stroke/death. Combined perioperative
stroke/death occurred in 10/636 (1.6%) patients in the in-
tention-to-treat cohort. Strokes occurred in 7/636 (1.1%)
patients (5/412 (1.2%) in PC and 2/224 (0.9%) in EV; P
1.0). Across all CEAs performed during this timeframe, peri-
operative death occurred in 3/636 (0.5%) patients, 1/412
(0.2%) in PC and 2/224 (0.9%) in EV; P  .29. In patients
with at least 1-year ultrasound follow-up (n  290), periop-
Table I. Preoperative characteristics of patients with comp
Clinical factor Patch (n  155)
Symptomatic* 29.7% (46/155)
TIA/AFX 22.6% (35/155)
Stroke 7.1% (11/155)
Retinal Stroke 1.3% (2/155)
Vertebrobasilar Symptoms 1.3% (2/155)
Preoperative ultrasound
ICA Velocity (cm/sec) 412  131 (13-766)
ICA/CCA 5.61  2.43 (0.15-16
TIA/AFX, transient ischemic attacks or amaurosis fugax; ICA, internal car
artery.
*Includes patients with multiple types of symptoms
†Fisher exact t test shown
Table II. Demographic and clinical features of patients w
Patch cohort (n  155)
Age (years) 73.4  10.3 (36-95)
Gender male 57.4% (89/155)
Smoking 74.4% (90/121)
HTN 85.1% (131/154)
Renal failure 18.7% (29/155)
DM 24.7% (38/154)
Side (right) 54.8% (85/155)
Hypercholesterolemia 71.4% (110/154)
PVD 29.2% (45/154)
CAD 69.5% (107/154)
Atrial fibrillation 16.9% (26/154)
Cholesterol 184  54.1 (0-446)
Triglycerides 192  174 (52-1623)
LDL 107  37.9 (20-186)
HDL 42.3  13.2 (9-84)
HTN, hypertension; DM, diabetes; PVD, peripheral vascular disease; CA
sity lipoproteins.
Table III. Perioperative complications for patients with co
Patch (n  155)
Hematoma 1.9% (3/155)
MI 0.7% (1/155)
Stroke 1.9% (3/155)
CN injury 0% (0/155)
TIA 1.3% (2/155)
MI, myocardial infarction; CN, cranial nerve; TIA, transient ischemic attac
*Fisher exact t test shown.erative strokes occurred in 3/290 (1.1%) of patients. All ofthese occurred in PC, P  .25 (Table III). With regards to the
functional capacity of patients after their stroke, two patients
had a Rankin score of 1 (no significant disability despite
symptoms; able to carry out all usual duties and activities), and
one patient had aRankin score of 2 (slight disability; unable to
carry out all previous activities, but able to look after own
affairs without assistance). No patient required re-exploration
due to their hematoma. One patient in the eversion cohort
experienced transient swallowing difficulty postoperatively
with resolution within 1 week. This was considered a cranial
anatomic follow-up
Eversion (n  135) P-value
31.0% (42/135) .70
20.0% (27/135) .67
11.9% (16/135) .22
5.2% (7/135) .09†
3.7% (5/135) .26†
419  117 (160-730) .68
5.74  1.98 (1.62-12.2) .66
tery; ICA/CCA, peak systolic velocity ratio of internal to common carotid
mplete anatomic follow-up
Eversion cohort (n  135) P-value
74.1  9.7 (41-94) .58
62.7% (84/134) .36
74.6% (97/130) .97
93.3% (126/135) .03
9.6% (13/135) .03
23.0% (31/135) .73
51.1% (69/135) .53
85.9% (113/135) .003
25.9% (35/135) .53
52.6% (70/132) .003
17.8% (24/135) .84
178  62.7 (0-303) .40
174  169 (0-1167) .48
99  51.2 (0-218) .26
47.0  24.0 (0-182) .1
ronary artery disease; LDL, low density lipoproteins; HDL, high den-
ete anatomic follow-up
Eversion (n  135) P-value
3.0% (4/135) .71*
1.5% (1/135) .59*
0% (0/135) .25*
0.8% (1/135) .47*
2.2% (3/135) .66*lete
.38)
otid arith co
D, complnerve injury.
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(1.7%) of patients in the intention to treat cohort, 6/412
(1.5%) in PC and 5/224 (2.2%) in EV; P .53. In patients
with at least 1-year ultrasound follow-up (n  290), MI
occurred in 3/290 (1.0%) of patients, 1/155 (0.7%) in PC,
and 2/135 (1.5%) in EV; P  .6.
Restenosis. Preoperative duplex indices of carotid ste-
nosis were similar between PC and EV groups. These
results, along with the surgical indications for CEA are
summarized in Table I. For the group of patients with
long-term follow-up imaging, mean follow-up was 5.5
years (1.0 to 11.7 years; median 5.5 years) for the PC group
and 3.5 years (1.0 to 5.1 years; median 3.5 years) for the EV
group.
Overall, “moderate” restenosis (as defined above) oc-
curred in 21.9% (34/155) patients in PC and 14.1% (19/
135) in EV; P  .08. Early (within 2 months) moderate
restenosis occurred in 5.8% (9/155) of patients in PC and
6.7% (9/135) of patients in the EV group; P  .76. Late
moderate restenosis occurred in 16.1% (25/155) of pa-
tients in PC (mean follow-up: 5.5 years) and 7.4% (10/
135) of patients in EV (mean follow-up: 3.5 years), P .02
and none were considered for reintervention. Further eval-
uation of moderate stenosis with Kaplan Meier life table
analysis showed no significant difference between the two
groups (Fig 1); P  .91. Overall “severe” restenosis
(70%) occurred in 16 (5.5%) of patients, eight each
(5.2%) in PC and (5.9%) EV; P  .78. Early or persistent
severe restenosis occurred in two patients (0.7%), one each
for PC (0.6%) and EV (0.7%) groups, (P  .92) likely
representing “persistent” rather than recurrent stenoses.
Late severe restenosis occurred in 14 (4.8%) of patients,
seven each for PC (4.5%) and EV (5.2%) groups; (P .79),
with follow-up intervals noted above. Additional analysis by
Kaplan-Meier analysis showed no difference (P  .54)
between PC and EV groups (Fig 2).
Re-do CEA. In the group of patients with at least
1-year follow-up, 11/290 (3.8%) patients required rein-
tervention on their operated carotid artery; only a single
patient had recurrent symptoms (TIA). In EV, four
(3.0%) patients needed reintervention at a mean fol-
low-up of 1.57  0.30 years. Two patients had re-do
CEA with patch, and two had carotid stents placed. All
seven (4.5%) of the patients in PC that needed reinter-
vention had open re-do CEA procedures at a mean
follow-up of 2.58  2.18 years.
Late stroke. Three strokes (3/290; 1.1%) occurred
during late follow-up, all in the PC group. Only one stroke
could be ascribed to the operated carotid artery. This
patient is a 66-year-old female with heparin-induced
thrombocytopenia who had a previous postoperative stroke
and on return to the operating room had platelet thrombi
forming on theDacron patch. She eventually recovered and
was placed on Warfarin. A subsequent stroke occurred 1.5
years later when she became subtherapeutic on her antico-
agulation in the presence of a critical recurrent stenosis.
Late survival. In the cohort of patients with anatomic
follow-up, crude mortality was 18.2% (28/155) in the PCgroup (5.5 year mean follow-up) and 6.7% (9/135) deaths
in the EV group (3.5 year mean follow-up); P  .04. This
difference is likely due to differences in follow-up duration
as Kaplan-Meier life table analysis for survival showed no
difference between EV and PC ( P  .86). Fig 3 demon-
strates a 3- and 5-year survival of 97%  1% vs 93%  3%
and 88%  3% vs 92%  3% for PC vs EV groups, respec-
tively.
Logistic regression analysis was performed to assess
variables associated with death, stroke, and moderate and
severe restenosis. Increasing age at operation (odds ratio
[OR] 1.14 [1.1-1.2], P  .001); smoking: (OR 5.4 [1.5-
20.0], P  .01) and diabetes (OR 2.9 [1.1-7.5], P  .03),
were all associated with inferior survival in our cohort.
Female gender: (OR 3.2 [CI: 1.61-6.7], P  .001) and a
history of peripheral vascular disease (OR 2.03 [CI: 1.0-
4.1], P  .048), increased the likelihood of moderate
restenosis in our cohort. Female sex (OR 3.72 [1.02-13.5],
P .046) was associated with severe restenosis irrespective
of surgical technique. Univariate analysis (no independent
correlates were found) of factors associated with late stroke
showed that female gender (OR 7.6 [CI: 0.88-66.7], P 
.042) was significantly associated with stroke in our pa-
Fig 1. Life table analysis of moderate restenosis comparison for
patch and eversion cohorts.tients.
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The safety and efficacy of CEA has been demonstrated
in a variety of level 1 data,1-4 administrative and NSQIP
database studies9, 20 and large single center series.6, 7 How-
ever CEA is complicated by a finite rate of restenosis, which
in some cases may require reintervention, although criteria
for same are not evidence based. Our published data on
CEA analyzed anatomic durability during a median
follow-up period of 6 years, and identified a 7.7% failure
rate (severe restenosis/occlusion, 4.5%; or reoperative
CEA, 3.2%) and an overall perioperative stroke/death rate
of 1.4%.6 Further study identified both risk factors for
restenosis and the favorable impact of HMG-CoA reduc-
tase inhibitors on restenosis.17 Intrigued with the concept
that eversion CEA could potentially improve restenosis
rates, we adopted eversion endarterectomy in 2001. The
current study was designed to assess the impact of eversion
on restenosis after CEA with the desirable concept that the
“control” patch CEA cohort consisted of our immediately
preceding experience. Consequently, our length of
follow-up is longer for patients in the patch (5.5 years) vs
those in our eversion (3.5 years) CEA cohort.
Several advantages have been cited in favor of the
eversion technique. Eversion CEA avoids the use of pros-
Fig 2. Life table analysis of severe restenosis comparison for patch
and eversion cohorts.thetic material and is particularly useful in situations inwhich the internal carotid artery is coiled or kinked.21
Concerns with carotid eversion include difficulty in visual-
ization of the endarterectomy end-point, increased techni-
cal demand, difficulty when a shunt needs to be used, and
the possibility that a distal flap may remain if the endarter-
ectomy endpoint is not properly performed.16,22 With re-
gards to the use of a shunt, reports from multiple groups
with extensive experience have described the safety and
feasibility of shunting during carotid eversion.8,23 How-
ever, in our opinion, shunt use remains more cumbersome
and technically demanding when using the eversion tech-
nique. Accordingly, when EEG changes, or the response of
the patient who was awake in the case of local anesthesia,
mandate the use of a shunt, longitudinal arteriotomy and
patch closure is our preferred method. Reports from mul-
tiple centers, which include retrospective studies and stud-
ies by individual surgeons, show that clinical results with
the eversion technique are comparable to those obtained
with traditional CEA.8,15,24-27 Some nonrandomized, pro-
spective studies, report improved results for eversion CEA
compared with patch CEA in both perioperative and long-
term outcomes.22,28-30
Eversion CEA has been further validated in prospec-
tive, randomized trials.23,31 The largest of these studies is
the Eversion Carotid Endarterectomy Versus Standard
Trial (EVEREST). This study included some 1353 pa-
tients, 678 for the conventional group and 675 in the
Fig 3. Life table analysis of survival comparison for patch and
eversion.eversion group. EVEREST found no statistical difference in
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dard (patch and primary closure) and eversion CEA. Sub-
group analysis showed that restenosis rates were statistically
comparable (2.8% vs 1.5%) for eversion and patch, respec-
tively, while both had significantly lower restenosis rates
than primary closure.31 More recently, a systematic review
of the literature by the same authors, which included five
controlled trials and almost 2500 patients, found that ever-
sion CEA was associated with a lower risk of restenosis,
when compared with conventional (patch) CEA, albeit
rates of clinically relevant outcomes such as stroke and
death were equal.16 The authors of this review argued that
the inability to see clinical differences despite the differ-
ences in restenosis rates might be related to sample size.
In view of excellent perioperative outcomes achieved in
contemporary practice with CEA, we anticipated no discern-
able impact on same with eversion CEA.6 Our data in this
regard are consistent with substantial literature comparing
perioperative outcomes with the two surgical techniques. Our
1% combined perioperative stroke/death rate is consistent
with that noted in the EVEREST trial (1.3%) and the Co-
chrane Systematic Review (2.1%).16,31 It is important to note
that the Cochrane Review included four trials which com-
pared eversion vs patch angioplasty as in our series, and one,
(EVEREST), which included CEA with primary repair in the
conventional CEA group.23,26,31-33 Further subgroup analy-
sis of ipsilateral strokes at 4 years in the EVEREST trial, which
compared eversion and patch separately, still showed no dif-
ference (3.9%, 1.2%, P  .3) between these two techniques.31
Subgroup analysis of the Cochrane Review again revealed no
differences between the patch and eversion groups, in the
parameters of perioperative strokes (1.7% vs 2.4%) or periop-
erative death (2.0% vs 1.9%) for eversion and patch, respec-
tively.34 Even though all of the perioperative strokes in our
cohort occurred in the patch group, the stroke rate was not
different when comparing the patch and eversion groups (P
.25). This result is consistent with that found by Ballotta et al
in a prospective trial of patients undergoing sequential bilat-
eral CEA with patch and eversion techniques32 as well as in a
larger related study published by the same group.23 Compar-
ison with other studies is complicated in some circumstances,
since there is variation in the inclusionof primary closure in the
conventional CEA groups. What is consistent is that eversion
is at least as effective and even superior to conventionalCEA in
consideration of perioperative stroke and death as an end-
point.8,22,25,26,28,29,33,35 Our analysis demonstrated equiva-
lent late mortality for the two procedures after life table
analysis corrected for the discrepancy in follow-up intervals.
Restenosis after CEA has been extensively studied, yet
will vary as a function of defining criteria and follow-up
intervals. It is also recognized that there is a bimodal
temporal distribution of restenosis reflecting early intimal
hyperplasia (largely within 1.5 years of surgery) and later
progressive atherosclerosis, each with likely separate (albeit
poorly defined) risk factors. With respect to the technical
component of the operation, there is consensus that patch
closure is superior to primary closure,23,31 but as noted
above, the literature claiming superiority of eversion (vspatch) is less convincing. In this report, the roughly 1%/
year cumulative incidence of severe recurrent stenosis is
consistent with our prior experience6 and compares favor-
ably with the3%/year reported in the literature. Further-
more, there was no difference in restenosis between ever-
sion and patch, consistent with both the EVEREST and
Cochrane Systematic Review.31,34 This is also consistent
with other smaller nonrandomized and single surgeon se-
ries that either show no differences in restenosis rates
between eversion and patch angioplasty or show superiority
of eversion over patch repair.21-23,29,32 Furthermore, it has
been suggested that the anatomic localization of recurrent
stenosis might differ with the two techniques. Focus on the
common carotid artery, (particularly when the latter is
heavily diseased) as the site of recurrent stenoses was em-
phasized by Green et al.22 However, in this study, most
severe recurrent lesions occurred in the internal carotid
artery with no discernable patterns noted between eversion
vs patch CEA. One contemporary study has shown that
eversion CEA may have significantly higher rates of reste-
nosis when compared against patch CEA.35 Brothers re-
ported rates of 50% restenosis as 38% and 6% (P  .001)
for eversion and patch CEA at 36 months by life table
analysis. Our life table analysis at 36 months show 20% and
16% (P .91) moderate (ie, non- flow-limiting) restenosis
rates for patch and eversion CEA, likely indicating similar
“remodeling biology” for the two operations, and also
reflecting the stringent duplex criteria utilized herein.
However, Brothers reported80% restenosis of 6% and 5%
for eversion and patch CEA respectively at 36 months by
life table analysis; these figures are quite similar to our data.
Aside from technical components of CEA, our data are
consistent with prior literature identifying female gender as
associated with a four-fold increased risk of restenosis.36,37
Others have reported that perioperative outcomes are also
inferior in females.38 There are recent data to support the
notion that carotid arteries are smaller in women, even after
adjusting for body size, age and blood pressure.39 How-
ever, at least one study demonstrated equivalent restenosis
for men and women after EV, and also noted luminal
expansion of the internal carotid artery after eversion end-
arterectomy.40 Precise data on ICA diameter are not avail-
able from this study, and it remains unknown if increased
restenosis rates reported in women indeed reflect a gender
effect, or if female gender is a surrogate for smaller arteries.
Finally, a history of peripheral vascular disease increased the
likelihood of moderate restenosis in our cohort, consistent
with other reports.37
There are several limitations to our study; first, our
sample size is likely not large enough to detect absolute
differences between the two surgical techniques. If reste-
nosis rates reported in the EVEREST trial are used as a
benchmark, simple power calculations indicate that some
2000 patients per cohort would be required to detect such
differences with 80% power. While our study is underpow-
ered with respect to demonstrating statistical differences in
restenosis rates, it demonstrates that good results can be
obtained with patch and eversion CEA. In addition, our
JOURNAL OF VASCULAR SURGERY
Volume 46, Number 1 Crawford et al 47results demonstrate that previously reported differences
between patch and eversion restenosis rates cannot be
directly attributed to technical variation across single-sur-
geon experiences.35 Although we recognize this as a limi-
tation, previous report comparing these two techniques
have found significant differences in restenosis rates with
comparable numbers of patients.35
A second limitation of our study is the number of
patients (approximately 50% of total which includes de-
ceased patients) for whom we did not have available long-
term Duplex data. This limitation can be ascribed partly to
the retrospective nature of our study, and our requirement
for objective ultrasound velocities (not mere qualitative
descriptions) for inclusion into the study. Sincemany of our
patients are from remote geographic regions, their fol-
low-up was done with their primary care physicians who
referred patients back only when major abnormalities were
noted in their ultrasounds. Even with our current follow-up
numbers, the EV and PC groups were well matched in
terms of the severity of their disease as well as their comor-
bidities and demographic features.
CONCLUSION
These data are consistent with prior randomized stud-
ies and indicate that restenosis rates are similar between
eversion and patch CEA, suggesting that such restenosis
rates represent biological remodeling phenomenon rather
than technical variations of operation. Accordingly, sur-
geons obtaining good results with patch closure should not
adopt eversion in anticipation of improving restenosis rates.
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